VAERS reports by lot

GSK DTaP/Tdap lot 5KR3R: VAERS reports

23 VAERS reports list lot 5KR3R as a GSK DTaP/Tdap vaccine, received between 2025-05-20 and 2026-03-30. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
4%
Marked serious
1
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction928%
General / Systemic (non-local)722%
Neurological39%
Allergic / Anaphylactic39%
Respiratory39%
Gastrointestinal26%
Cardiac / Cardiovascular13%
Thrombotic / Hematological13%
Musculoskeletal13%
Dermatological (non-injection-site)13%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Texas3
Washington3
Arizona2
California2
Maine2
New Hampshire1
Colorado1
Massachusetts1
North Carolina1
Georgia1
Michigan1
Virginia1

Reports by month received

MonthReportsBar
2025-051
2025-061
2025-077
2025-082
2025-092
2025-105
2025-112
2025-122
2026-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): 5G23D · 5H773 · 5H95B · 5YB5G · 745N2 · 7559R

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.